Lord Balfe
Lords / Conservative / Life peer
Lord Balfe's full title is The Lord Balfe. His name is Richard Andrew Balfe, and he is a current member of the House of Lords.
| Stock | Sector / Industry | P/L % | MPV |
|
|---|---|---|---|---|
|
GSK
Glaxosmithkline |
Healthcare / Drug Manufacturers - General | 6.63% | £74,643.34 |
|
AZN.L
Astrazeneca |
Healthcare / Drug Manufacturers - General | 4.34% | £73,038.92 |
|
ULVR.L
Unilever |
Consumer Defensive / Household & Personal Products | -3.68% | £67,423.67 |
* Minimum Potential Value based on £70,000.00 invested at time of declaration.
** Interest ceased/exited on filed date.
| Since | Company | Active | Companies House |
|---|---|---|---|
| Jun 2017 |
|
Ceased 8th Apr '25 | |
| May 2021 |
|
Ceased 8th Apr '25 |
| Filed | Name | Amount | Type | Corporate | Companies House |
|---|---|---|---|---|---|
| 10th Oct '23 | Visit to Ankara, Turkey, 5-8 October 2023, to attend 4th Special Congress of AK Parti; travel and three nights’ accommodation plus most meals were paid for by AK Parti | £0.00 | Received |
| Filed | Destination | Amount |
|---|---|---|
| 10th Oct '23 | Ankara, Türkiye | £0.00 |